Ariel Effrigan

So that is very significantly depends on the population, depends on how the length of the contract, et cetera.

But typically it will operate either on a per member per month basis or in a shared savings model.

So based on the savings that we generate for the client, we're able to take a bonus from that and use that as our payment essentially.

So really they're just paying for the value they're getting.

Yeah, no.

So contracts in our space are typically in the millions of dollars.

We could be.

It depends on the size, you know, half a million dollars, something like that.

And pilots obviously are cheaper, but it just depends on the size of the client.

But typically large enterprise clients are going to be spending millions of dollars.

Yeah.

So we raised about $8 million or $8 to $10 million seed round.

And we've launched, we're live, we've done clinical studies.

We're working with some of the largest health insurance companies in the world and in the US, as well as some of the largest health systems.

So we did that at the end of last year, beginning of this year.

Yeah.

So it's both a function of just our needs in terms of research and developing the AI and our clinical teams, and also just the growth.

We've had so much interest in our platform because of the impact we can have on patients.

And so really it allows us to essentially get to that impact and validation, the level of validation you really need in healthcare.

Uh, no, we have customers that are, uh, paying and working with us.